Patent details
EP3077002 Title: COMBINATION OF PI3K-INHIBITORS
Basic Information
- Publication number:
- EP3077002
- PCT Application Number:
- EP2014075886
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP148052665
- PCT Publication Number:
- WO2015082322
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF PI3K-INHIBITORS
- French Title of Invention:
- COMBINAISONS D'INHIBITEURS DE PI3K
- German Title of Invention:
- KOMBINATION VON PI3K-INHIBITOREN
- SPC Number:
Dates
- Filing date:
- 28/11/2014
- Grant date:
- 22/04/2020
- EP Publication Date:
- 12/10/2016
- PCT Publication Date:
- 11/06/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/04/2020
- EP B1 Publication Date:
- 22/04/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 28/11/2020
- Expiration date:
- 28/11/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/04/2020
- Name:
- Bayer Pharma Aktiengesellschaft
- Address:
- Müllerstrasse 178, 13353 Berlin, Germany (DE)
Inventor
- Name:
- LIU, Ningshu
- Address:
- Germany (DE)
Priority
- Priority Number:
- 13195485
- Priority Date:
- 03/12/2013
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 31/519; A61K 31/5377; A61K 33/14; A61K 45/06; A61K 51/02; A61P 35/00; A61P 35/04;
Publication
European Patent Bulletin
- Issue number:
- 202017
- Publication date:
- 22/04/2020
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|